Thomas Mühlenberg

1.1k total citations
28 papers, 725 citations indexed

About

Thomas Mühlenberg is a scholar working on Gastroenterology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Thomas Mühlenberg has authored 28 papers receiving a total of 725 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Gastroenterology, 20 papers in Pulmonary and Respiratory Medicine and 7 papers in Hematology. Recurrent topics in Thomas Mühlenberg's work include Gastrointestinal Tumor Research and Treatment (21 papers), Sarcoma Diagnosis and Treatment (11 papers) and Gastric Cancer Management and Outcomes (7 papers). Thomas Mühlenberg is often cited by papers focused on Gastrointestinal Tumor Research and Treatment (21 papers), Sarcoma Diagnosis and Treatment (11 papers) and Gastric Cancer Management and Outcomes (7 papers). Thomas Mühlenberg collaborates with scholars based in Germany, United States and Japan. Thomas Mühlenberg's co-authors include Sebastian Bauer, Martin Schüler, Jonathan A. Fletcher, Julia Ketzer, Florian Grabellus, Daniel Rauh, Takahiro Taguchi, G. Taeger, Jonas Lategahn and Marina Keul and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Thomas Mühlenberg

25 papers receiving 709 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Mühlenberg Germany 15 336 279 227 168 107 28 725
Mar Abad Spain 11 221 0.7× 121 0.4× 87 0.4× 172 1.0× 33 0.3× 25 483
Christopher Riley United States 8 179 0.5× 117 0.4× 72 0.3× 177 1.1× 12 0.1× 11 514
S. Curley United States 8 287 0.9× 134 0.5× 51 0.2× 274 1.6× 15 0.1× 12 606
M López Italy 14 150 0.4× 258 0.9× 42 0.2× 368 2.2× 11 0.1× 33 724
Aria Vaishnavi United States 7 461 1.4× 530 1.9× 17 0.1× 475 2.8× 77 0.7× 9 974
Ruediger Rueger Switzerland 9 500 1.5× 215 0.8× 15 0.1× 422 2.5× 61 0.6× 12 769
Tessa Y. S. Le Large Netherlands 15 226 0.7× 116 0.4× 54 0.2× 407 2.4× 7 0.1× 28 656
Raul Ayala United States 9 483 1.4× 253 0.9× 16 0.1× 356 2.1× 28 0.3× 18 830
Henry Xiong United States 11 342 1.0× 303 1.1× 32 0.1× 769 4.6× 10 0.1× 20 1.1k

Countries citing papers authored by Thomas Mühlenberg

Since Specialization
Citations

This map shows the geographic impact of Thomas Mühlenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Mühlenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Mühlenberg more than expected).

Fields of papers citing papers by Thomas Mühlenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Mühlenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Mühlenberg. The network helps show where Thomas Mühlenberg may publish in the future.

Co-authorship network of co-authors of Thomas Mühlenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Mühlenberg. A scholar is included among the top collaborators of Thomas Mühlenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Mühlenberg. Thomas Mühlenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Falkenhorst, Johanna, Philipp Ivanyi, Rainer Hamacher, et al.. (2025). Phase II Trial of Ponatinib in Patients with Metastatic Gastrointestinal Stromal Tumor following Failure or Intolerance of Prior Therapy with Imatinib (POETIG Trial). Clinical Cancer Research. 31(19). 4059–4069.
2.
Gontla, Rajesh, Thomas Mühlenberg, Marina Keul, et al.. (2025). Design, Synthesis, and SAR of Covalent KIT and PDGFRA Inhibitors─Exploring Their Potential in Targeting GIST. Journal of Medicinal Chemistry. 68(3). 3238–3259.
3.
Gontla, Rajesh, Thomas Mühlenberg, Jörn Weisner, et al.. (2024). Avapritinib-based SAR studies unveil a binding pocket in KIT and PDGFRA. Nature Communications. 15(1). 63–63. 16 indexed citations
4.
Heinrich, Michael C., Janice Patterson, Carol Beadling, et al.. (2019). Genomic aberrations in cell cycle genes predict progression of KIT-mutant gastrointestinal stromal tumors (GISTs). SHILAP Revista de lepidopterología. 9(1). 3–3. 25 indexed citations
5.
Keul, Marina, Thomas Mühlenberg, Julia Ketzer, et al.. (2017). Inhibitors to Overcome Secondary Mutations in the Stem Cell Factor Receptor KIT. Journal of Medicinal Chemistry. 60(21). 8801–8815. 8 indexed citations
6.
Engel, Julian, Christian Becker, Jonas Lategahn, et al.. (2016). Inhibition wirkstoffresistenter Mutationsvarianten der Rezeptortyrosinkinase EGFR. Angewandte Chemie. 128(36). 11069–11073. 5 indexed citations
7.
Engel, Julian, Christian Becker, Jonas Lategahn, et al.. (2016). Insight into the Inhibition of Drug‐Resistant Mutants of the Receptor Tyrosine Kinase EGFR. Angewandte Chemie International Edition. 55(36). 10909–10912. 52 indexed citations
8.
Weisner, Jörn, Rajesh Gontla, Sebastian Oeck, et al.. (2015). Covalent‐Allosteric Kinase Inhibitors. Angewandte Chemie International Edition. 54(35). 10313–10316. 87 indexed citations
9.
Mühlenberg, Thomas, Susanne Grünewald, Jürgen Treckmann, et al.. (2015). Inhibition of KIT-Glycosylation by 2-Deoxyglucose Abrogates KIT-Signaling and Combination with ABT-263 Synergistically Induces Apoptosis in Gastrointestinal Stromal Tumor. PLoS ONE. 10(3). e0120531–e0120531. 13 indexed citations
10.
Bauer, Sebastian, Thomas Herold, Thomas Mühlenberg, et al.. (2015). Plasma sequencing to detect a multitude of secondary KIT resistance mutations in metastatic gastrointestinal stromal tumors (GIST).. Journal of Clinical Oncology. 33(15_suppl). 10518–10518. 9 indexed citations
11.
Bauer, Sebastian, Thomas Mühlenberg, Florian Grabellus, et al.. (2014). Phase I study of panobinostat and imatinib in patients with treatment-refractory metastatic gastrointestinal stromal tumors. British Journal of Cancer. 110(5). 1155–1162. 39 indexed citations
12.
Grabellus, Florian, Loretta Ferrera, Luis J. V. Galietta, et al.. (2013). DOG1 Regulates Growth and IGFBP5 in Gastrointestinal Stromal Tumors. Cancer Research. 73(12). 3661–3670. 67 indexed citations
13.
Edris, Badreddin, Stephen B. Willingham, Kipp Weiskopf, et al.. (2013). Use of a KIT-specific monoclonal antibody to bypass imatinib resistance in gastrointestinal stromal tumors. OncoImmunology. 2(6). e24452–e24452. 3 indexed citations
14.
Edris, Badreddin, Stephen B. Willingham, Kipp Weiskopf, et al.. (2013). Anti-KIT monoclonal antibody inhibits imatinib-resistant gastrointestinal stromal tumor growth. Proceedings of the National Academy of Sciences. 110(9). 3501–3506. 44 indexed citations
15.
Edris, Badreddin, Íñigo Espinosa, Thomas Mühlenberg, et al.. (2012). ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour. The Journal of Pathology. 227(2). 223–233. 66 indexed citations
16.
Mühlenberg, Thomas, Florian Grabellus, Brian P. Rubin, et al.. (2012). p53 Modulation as a Therapeutic Strategy in Gastrointestinal Stromal Tumors. PLoS ONE. 7(5). e37776–e37776. 43 indexed citations
17.
Mühlenberg, Thomas, J. Fletcher, Florian Grabellus, Martin Schüler, & Sebastian Bauer. (2010). 211 Effective therapeutic sensitization of gastrointestinal stromal tumors by a BH3 mimetic. European Journal of Cancer Supplements. 8(7). 69–70. 1 indexed citations
18.
Mühlenberg, Thomas, Yixiang Zhang, Andrew J. Wagner, et al.. (2009). Inhibitors of Deacetylases Suppress Oncogenic KIT Signaling, Acetylate HSP90, and Induce Apoptosis in Gastrointestinal Stromal Tumors. Cancer Research. 69(17). 6941–6950. 74 indexed citations
19.
Bauer, Sebastian, Joshua A. Parry, Thomas Mühlenberg, et al.. (2009). Proapoptotic Activity of Bortezomib in Gastrointestinal Stromal Tumor Cells. Cancer Research. 70(1). 150–159. 34 indexed citations
20.
Bauer, Sebastian, Thomas Mühlenberg, Michael Leahy, et al.. (2009). Therapeutic Potential of Mdm2 Inhibition in Malignant Germ Cell Tumours. European Urology. 57(4). 679–687. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mar Abad Breakdown of academic impact, for papers by Christopher Riley Breakdown of academic impact, for papers by S. Curley Breakdown of academic impact, for papers by M López Breakdown of academic impact, for papers by Aria Vaishnavi Breakdown of academic impact, for papers by Ruediger Rueger Breakdown of academic impact, for papers by Tessa Y. S. Le Large Breakdown of academic impact, for papers by Raul Ayala Breakdown of academic impact, for papers by Henry Xiong
Rankless by CCL
2026